1. Hardman J, Graf O, Kouloumberis PE, Gao WH, Chan M, Roitberg BZ. Clinical and functional outcomes of laminoplasty and laminectomy. Neurol Res 2010;32:416–20.
2. Watkins MB. Posterolateral fusion of the lumbar and lumbosacral spine. J Bone Joint Surg Am 1953;35- A:1014–8.
4. Lee JS, Suh KT. Posterior lumbar interbody fusion with an autogenous iliac crest bone graft in the treatment of pyogenic spondylodiscitis. J Bone Joint Surg Br 2006;88:765–70.
6. Sasso RC, LeHuec JC, Shaffrey C; Spine Interbody Research Group. Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: a prospective patient satisfaction outcome assessment. J Spinal Disord Tech 2005;18 Suppl:S77–81.
7. Summers BN, Eisenstein SM. Donor site pain from the ilium: a complication of lumbar spine fusion. J Bone Joint Surg Br 1989;71:677–80.
8. Biswas D, Bible JE, Whang PH, et al. Augmented demineralized bone matrix: a potential alternative for posterolateral lumbar spinal fusion. Am J Orthop (Belle Mead NJ) 2010;39:531–8.
9. Brandenberg G, Leibrock LG, Shuman R, Malette WG, Quigley H. Chitosan: a new topical hemostatic agent for diffuse capillary bleeding in brain tissue. Neurosurgery 1984;15:9–13.
11. Shi C, Zhu Y, Ran X, Wang M, Su Y, Cheng T. Therapeutic potential of chitosan and its derivatives in regenerative medicine. J Surg Res 2006;133:185–92.
12. Hing KA, Best SM, Tanner KE, Bonfield W, Revell PA. Mediation of bone ingrowth in porous hydroxyapatite bone graft substitutes. J Biomed Mater Res A 2004;68:187–200.
14. Ding M, Koroma KE, Sorensen JR, et al. Collagenhydroxyapatite composite substitute and bone marrow nuclear cells on posterolateral spine fusion in sheep. J Biomater Appl 2019;34:365–74.
15. Yoshida A, Miyazaki T, Ishida E, Ashizuka M. Preparation of bioactive chitosan-hydroxyapatite nanocomposites for bone repair through mechanochemical reaction. Mater Trans 2004;45:994–8.
16. Zo SM, Singh D, Kumar A, Cho YW, Oh TH, Han SS. Chitosan-hydroxyapatite macroporous matrix for bone tissue engineering. Curr Sci 2012;103:1438–46.
17. Lenke LG, Bridwell KH, Bullis D, Betz RR, Baldus C, Schoenecker PL. Results of in situ fusion for isthmic spondylolisthesis. J Spinal Disord 1992;5:433–42.
18. Dimar JR 2nd, Ante WA, Zhang YP, Glassman SD. The effects of nonsteroidal anti-inflammatory drugs on posterior spinal fusions in the rat. Spine (Phila Pa 1976) 1996;21:1870–6.
19. Lee JS, Baek SD, Venkatesan J, et al. In vivo study of chitosan-natural nano hydroxyapatite scaffolds for bone tissue regeneration. Int J Biol Macromol 2014;67:360–6.
20. Yuan H, Chen N, Lu X, Zheng B. Experimental study of natural hydroxyapatite/chitosan composite on reconstructing bone defects. J Nanjing Med Univ 2008;22:372–5.
22. Vega-Ruiz B, Ramos-Zuniga R, Duran IS, UrsielOrtega Y. Biomaterials and surgical applications: the translational perspective. Transl Surg 2017;2:85–102.
24. Massie JB, Huang B, Malkmus S, et al. A preclinical post laminectomy rat model mimics the human post laminectomy syndrome. J Neurosci Methods 2004;137:283–9.
25. Zhang J, Liu G, Wu Q, Zuo J, Qin Y, Wang J. Novel mesoporous hydroxyapatite/chitosan composite for bone repair. J Bionic Eng 2012;9:243–51.
26. Shin DA, Yang BM, Tae G, Kim YH, Kim HS, Kim HI. Enhanced spinal fusion using a biodegradable porous mesh container in a rat posterolateral spinal fusion model. Spine J 2014;14:408–15.
27. Cunningham BW, Shimamoto N, Sefter JC, et al. Osseointegration of autograft versus osteogenic protein-1 in posterolateral spinal arthrodesis: emphasis on the comparative mechanisms of bone induction. Spine J 2002;2:11–24.
29. Carvalho M, Costa LM, Pereira JE, et al. The role of hybrid chitosan membranes on scarring process following lumbar surgery: post-laminectomy experimental model. Neurol Res 2015;37:23–9.
30. Farrugia BL, Whitelock JM, Jung M, et al. The localisation of inflammatory cells and expression of associated proteoglycans in response to implanted chitosan. Biomaterials 2014;35:1462–77.